Furthermore, another report showed that ALA significantly decreases liver weight, liver cholesterol levels, and expression of cholesterol synthase (farnesyl pyrophosphate synthase) associated with hyperlipidemia (O'Reilly et al., 2020). This evidence concerns the gene FDPS and hyperlipidemia.